In a study comparing a small number of treatment-naive IDH-mutated and IDH-wt glioblastoma tumors, IDH-mutants were shown to contain less macrophages which displayed a more pro-inflammatory M1-like activation state, possibly contributing to the longer survival of these patients (Poon et al., 2019). This evidence concerns the gene IDH1 and glioblastoma.